SCHEMBL21701477

SCHEMBL21701477

O=C(Nc1ccc(N2CCC(Oc3ccccc3)CC2)cc1C(=O)O)c1cc2ccccc2[nH]1

nearest known ligand 0.48

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.47
CCKAR P32238 2/20 0.46
PRSS12 P56730 2/20 0.45
NPC1 O15118 1/20 0.45
LMNA P02545 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
NHERF1 O14745 1/20 0.45
NAMPT P43490 1/20 0.44
MALT1 Q9UDY8 1/20 0.43
CCKBR P32239 2/20 0.43
PIN1 Q13526 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21701473 0.81 NPC1 (0.51) KDM1ANPC1LMNARAB9ASMN1; SMN2
SCHEMBL21683036 0.79 RXFP1 (0.52) NPC1LMNARAB9ASMN1; SMN2NAMPT
SCHEMBL21701475 0.78 HDAC1 (0.52) PRSS12NPC1RAB9ASMN1; SMN2NAMPT
SCHEMBL21701476 0.74 OPRM1 (0.56) PRSS12NPC1LMNASMN1; SMN2MALT1
SCHEMBL13701154 0.74 NHERF1 (0.74) CCKARNPC1LMNARAB9ASMN1; SMN2
SCHEMBL1308465 0.73 NPC1 (0.59) CCKARNPC1LMNARAB9ASMN1; SMN2
SCHEMBL16701639 0.71 NPC1 (0.61) KDM1ANPC1LMNARAB9ASMN1; SMN2
SCHEMBL6834022 0.71 NPC1 (0.55) CCKARNPC1LMNARAB9ASMN1; SMN2
SCHEMBL21682938 0.68 NAMPT (0.49) NPC1LMNARAB9ANAMPT
SCHEMBL31162733 0.68 FFAR4 (0.59) NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020033944-A2 NON-POLYAMINE BASED POLYAMINE TRANSPORT INHIBITORS AND THEIR USE IN THE TREATMENT OF HUMAN CANCERS UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2020-02-13 WO disclosed